{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-002736","form_type":"8-K","ticker":"SENS","cik":"0001616543","company_name":"Senseonics Holdings, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.649926+00:00","generated_at":"2026-05-16T10:52:47.698210+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Senseonics Q4 2025 preliminary revenue $14.2M (+71% YoY); FY2025 $35.2M; guides FY2026 $58-62M","bullets":["Preliminary Q4 2025 revenue $14.2M (+71% YoY); FY2025 revenue $35.2M (+57% YoY); cash $94.3M.","Patient base grew 103% in Q4 2025 vs Q4 2024; largest new patient addition in company history.","Received FDA IDE approval to begin pivotal trial for self-powered Gemini sensor; first patients enrolled.","2026 revenue guidance $58-62M (65-76% growth); gross margin ~50%; commercial transition from Ascensia effective Jan 1, 2026.","First commercial patients using pump partner Sequel's twiist insulin delivery system with Eversense 365 compatibility."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-002736","json":"https://secwatch.observer/filing/0001104659-26-002736.json","markdown":"https://secwatch.observer/filing/0001104659-26-002736.md","text":"https://secwatch.observer/filing/0001104659-26-002736.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616543/000110465926002736/0001104659-26-002736-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616543/000110465926002736/tm262845d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:52:47.698210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}